New Vaccine
Practice this intermediate market entry case interview question from LEK in the Healthcare sector. Includes detailed problem prompt, clarifying questions, structured framework, and expert recommendation. Part of ProHub's 835+ consulting case library.
ProHub Comment
This is a quantitative market entry case requiring candidates to move beyond basic calculations toward strategic cost-benefit analysis. The key insight is recognizing that the vaccine is only cost-effective for certain baby weight segments, making selective market capture critical to viability.
Estimated Time
26 minutes
Difficulty
Medium
Source
Chicago Booth
22
/ 100
Our client is a large pharmaceutical corporation, and they have developed a new vaccine that prevents low birth weight infants from contracting staph infections. They have approached us to determine the potential for this vaccine.
Clarifying Information
- When the candidate asks what is meant by the ‘potential for this vaccine,’ explain that our client is looking for clarity around revenue potential and a cost-benefit analysis of administering the vaccine.
- Our client is looking to launch this product in the United States, and is not currently concerned about international potential.